SCHEMBL5380272

SCHEMBL5380272

COC(=O)c1cc(S(=O)(=O)Nc2ccc(SCc3ccccc3C(F)(F)F)cc2)ccc1C

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.45
SMN1; SMN2 Q16637 3/20 0.43
ALDH1A1 P00352 1/20 0.41
GAA P10253 1/20 0.41
MAPT P10636 1/20 0.41
ALOX15 P16050 1/20 0.41
TSHR P16473 1/20 0.41
HTT P42858 1/20 0.41
KIF11 P52732 2/20 0.40
PLAU P00749 1/20 0.40
AVPR2 P30518 2/20 0.39
GPR27 Q9NS67 2/20 0.39
PABPC1 P11940 1/20 0.39
KMT2A Q03164 1/20 0.39
MAPK1 P28482 1/20 0.39
PPARG P37231 1/20 0.39
PPARA Q07869 1/20 0.39
MGAT2 Q10469 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5382205 0.91 POLB (0.52) POLBSMN1; SMN2ALDH1A1AVPR2GPR27
SCHEMBL5376768 0.89 GPR27 (0.44) POLBSMN1; SMN2ALDH1A1GAAMAPT
SCHEMBL5376499 0.84 POLB (0.46) POLBSMN1; SMN2ALDH1A1GAAMAPT
SCHEMBL5391352 0.83 POLB (0.47) POLBSMN1; SMN2ALDH1A1GAAMAPT
SCHEMBL5368417 0.83 ALOX15 (0.48) POLBSMN1; SMN2ALDH1A1GAAMAPT
SCHEMBL5382518 0.81 POLB (0.47) POLBSMN1; SMN2ALDH1A1GAAMAPT
SCHEMBL5386615 0.81 POLB (0.50) POLBSMN1; SMN2ALOX15PLAUAVPR2
SCHEMBL5378678 0.80 POLB (0.50) POLBSMN1; SMN2ALDH1A1GAAMAPT
SCHEMBL5921903 0.80 HDAC3 (0.50) POLBSMN1; SMN2HTTPABPC1KMT2A
SCHEMBL5373887 0.80 POLB (0.49) POLBSMN1; SMN2ALDH1A1GAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-20060258723-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PFIZER INC 2006-11-16 US disclosed
US-20050228015-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-10-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050228015-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD POLB 1807/4885SMN1; SMN2 3404/4885ALDH1A1 2956/4885
US-20060258723-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARG, PPARA, PPARD POLB 2006/4885SMN1; SMN2 3296/4885ALDH1A1 2752/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.